Association for Ocular Pharmacology and Therapeutics--Seventh Meeting. 3-5 February 2005, Catania, Italy.
作者信息
Toris Carol
机构信息
University of Nebraska Medical Center, Department of Ophthalmology, Omaha, NE 68198-5840, USA.
出版信息
IDrugs. 2005 Mar;8(3):209-10.
PMID:15772890
Abstract
摘要
相似文献
1
Association for Ocular Pharmacology and Therapeutics--Seventh Meeting. 3-5 February 2005, Catania, Italy.
IDrugs. 2005 Mar;8(3):209-10.
2
Eyes on New Product Development.
J Ocul Pharmacol Ther. 2018 Jun;34(5):373. doi: 10.1089/jop.2018.29042.gdn. Epub 2018 May 9.
3
Drug delivery to the back of the eye.
Arch Soc Esp Oftalmol. 2007 Nov;82(11):667-8; 669-70.
4
Ophthalmic medications and pharmacology.
J Ophthalmic Nurs Technol. 1998 Jul-Aug;17(4):151-8.
5
Ocular pharmacology and therapeutics.
J Occup Med. 1971 Feb;13(2):92-6. doi: 10.1097/00043764-197102000-00007.
6
Drugs for some common eye disorders.
Treat Guidel Med Lett. 2007 Jan;5(53):1-8.
7
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
J Med Chem. 2008 Mar 27;51(6):1546-59. doi: 10.1021/jm7011276. Epub 2008 Feb 27.
8
Ocular pharmacology and toxicology.
Ophthalmology. 1996 Aug;103(8 Suppl):S118-42. doi: 10.1016/s0161-6420(96)30770-7.
9
Veterinary ophthalmic pharmacology and therapeutics--IA: Introduction.
Vet Med Small Anim Clin. 1968 Jun;63(6):547-53.
10
Anecortave (Alcon Laboratories).
IDrugs. 2005 Apr;8(4):327-34.
Zotero 插件